Mutual of America Capital Management LLC Has $537,000 Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Mutual of America Capital Management LLC reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 9.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,454 shares of the company’s stock after selling 751 shares during the period. Mutual of America Capital Management LLC’s holdings in Prestige Consumer Healthcare were worth $537,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in PBH. Lombard Odier Asset Management USA Corp bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth $550,000. CANADA LIFE ASSURANCE Co raised its stake in Prestige Consumer Healthcare by 19.4% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after purchasing an additional 7,715 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Prestige Consumer Healthcare by 12.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after purchasing an additional 1,120 shares in the last quarter. Atria Investments Inc bought a new stake in Prestige Consumer Healthcare in the 1st quarter valued at about $1,246,000. Finally, Public Employees Retirement System of Ohio grew its position in shares of Prestige Consumer Healthcare by 20.5% during the 1st quarter. Public Employees Retirement System of Ohio now owns 80,950 shares of the company’s stock worth $5,874,000 after purchasing an additional 13,760 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Insider Transactions at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares in the company, valued at $26,510,635.20. The trade was a 3.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Mary Beth Fritz sold 9,885 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the transaction, the senior vice president now directly owns 18,835 shares of the company’s stock, valued at approximately $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,810 shares of company stock valued at $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $83.18 on Wednesday. The firm has a 50 day moving average of $74.76 and a 200-day moving average of $70.88. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $86.36. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $4.11 billion, a PE ratio of 20.24, a PEG ratio of 2.39 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. The business had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company’s revenue was down .9% on a year-over-year basis. During the same period in the previous year, the business earned $1.07 earnings per share. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PBH has been the subject of several recent research reports. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $83.67.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.